[go: up one dir, main page]

AU2001230195A1 - Pharmaceutical compositions comprising terbinafine - Google Patents

Pharmaceutical compositions comprising terbinafine

Info

Publication number
AU2001230195A1
AU2001230195A1 AU2001230195A AU3019501A AU2001230195A1 AU 2001230195 A1 AU2001230195 A1 AU 2001230195A1 AU 2001230195 A AU2001230195 A AU 2001230195A AU 3019501 A AU3019501 A AU 3019501A AU 2001230195 A1 AU2001230195 A1 AU 2001230195A1
Authority
AU
Australia
Prior art keywords
terbinafine
pharmaceutical compositions
compositions
disintegrant
taste
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001230195A
Inventor
Dieter Becker
Andreas Carl Eugster
Patrice Guitard
Stefan Hirsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2001230195A1 publication Critical patent/AU2001230195A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Pharmaceutical compositions for oral administration comprising terbinafine, a buffering component and a disintegrant. The compositions show rapid disintegration and having taste-masking properties.
AU2001230195A 2000-01-20 2001-01-18 Pharmaceutical compositions comprising terbinafine Abandoned AU2001230195A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0001315 2000-01-20
GBGB0001315.1A GB0001315D0 (en) 2000-01-20 2000-01-20 Organic compounds
PCT/EP2001/000562 WO2001052895A1 (en) 2000-01-20 2001-01-18 Pharmaceutical compositions comprising terbinafine

Publications (1)

Publication Number Publication Date
AU2001230195A1 true AU2001230195A1 (en) 2001-07-31

Family

ID=9884039

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001230195A Abandoned AU2001230195A1 (en) 2000-01-20 2001-01-18 Pharmaceutical compositions comprising terbinafine

Country Status (10)

Country Link
US (2) US20030017200A1 (en)
EP (1) EP1259261B1 (en)
JP (1) JP2003520252A (en)
AT (1) ATE297760T1 (en)
AU (1) AU2001230195A1 (en)
DE (1) DE60111503T2 (en)
ES (1) ES2241777T3 (en)
GB (1) GB0001315D0 (en)
PT (1) PT1259261E (en)
WO (1) WO2001052895A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
AR034813A1 (en) * 2001-07-20 2004-03-17 Novartis Ag PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME
ATE346590T1 (en) * 2001-07-26 2006-12-15 Ethypharm Sa COATED ALLYLAMINES OR BENZYLAMINES CONTAINING GRANULES, METHOD FOR THE PRODUCTION AND ORAL DISPERSIBLE TABLETS CONTAINING THE COATED GRANULES
RU2214237C1 (en) * 2002-04-24 2003-10-20 Закрытое акционерное общество "Брынцалов-А" Antifungal agent "bramisil"
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
GB201511799D0 (en) * 2015-07-06 2015-08-19 Blueberry Therapeutics Ltd Composition and methods of treatment
KR20200035234A (en) 2017-05-12 2020-04-02 마발론 테라퓨틱스 리미티드 Substituted heterocyclic compounds as allosteric modulators of Group II metabolic glutamate receptors
CN110200929A (en) * 2018-12-14 2019-09-06 悦康药业集团上海制药有限公司 A kind of oral tablet and preparation method thereof containing terbinafine HCl
CN109674757A (en) * 2019-02-22 2019-04-26 济南康和医药科技有限公司 A kind of terbinafine HCl composition and preparation method thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
SE8103843L (en) * 1981-06-18 1982-12-19 Astra Laekemedel Ab PHARMACEUTICAL MIXTURE
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine
JPH0776172B2 (en) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 Matrice locks
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
US4894592A (en) * 1988-05-23 1990-01-16 Fusion Systems Corporation Electrodeless lamp energized by microwave energy
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US4975465A (en) * 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
US5292520A (en) * 1990-09-13 1994-03-08 Akzo N.V. Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
US5661170A (en) * 1994-03-21 1997-08-26 Woodward Laboratories, Inc. Antimicrobial compositions and methods for using the same
GB9509631D0 (en) * 1995-05-12 1995-07-05 Sandoz Ltd Antifungal combination
GB9513750D0 (en) * 1995-07-06 1995-09-06 Sandoz Ltd Use of allylamines
CN1152717C (en) * 1997-09-30 2004-06-09 第一制药株式会社 Oral Drugs
JP2000086503A (en) * 1998-09-07 2000-03-28 Pola Chem Ind Inc Tablet medicine composition

Also Published As

Publication number Publication date
EP1259261B1 (en) 2005-06-15
JP2003520252A (en) 2003-07-02
US20100197804A1 (en) 2010-08-05
GB0001315D0 (en) 2000-03-08
DE60111503T2 (en) 2006-05-18
ES2241777T3 (en) 2005-11-01
ATE297760T1 (en) 2005-07-15
DE60111503D1 (en) 2005-07-21
PT1259261E (en) 2005-10-31
US20030017200A1 (en) 2003-01-23
EP1259261A1 (en) 2002-11-27
WO2001052895A1 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
AP2002002558A0 (en) Pharmaceutical compositions containing polymer and drug assemblies.
AP2005003318A0 (en) Pharmaceutical compositions comprising a basic respectively acidic drug coumpound, a surfactant and a physiologically tolerable watersoluble acid respectively base.
MY150060A (en) Pharmaceutical compositions comprising colloidal silicon dioxide
ZA200407868B (en) 17alpha-Alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations.
MXPA03007215A (en) Pharmaceutical formulations.
EP0960621A3 (en) Pharmaceutical formulations comprising sildenafil
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
EP2311488A3 (en) Vaccine composition
GEP20074047B (en) Pramipexole once-daily dosage form
WO2001078680A3 (en) Pharmaceutical compositions comprising fluvastatin
WO2002100437A3 (en) Ophthalmic compositions comprising hyaluronic acid
AU2682401A (en) Flavonoid drug and dosage form, its production and use
BG108516A (en) Pharmaceutical formulation
UA90518C2 (en) Pharmaceutical composition in the form of a tablet suitable for dissolution in the buccal cavity, comprising a narcotic active ingredient and amine
WO2004071374A3 (en) Once a day orally administered pharmaceutical compositions
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
BR0312728A (en) Dispersible tablet formulation and process for its preparation
AU2001230195A1 (en) Pharmaceutical compositions comprising terbinafine
AP2004003066A0 (en) Pharmaceutical compositions based on azetidine derivatives.
WO2003035686A3 (en) Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
AU2001252225A1 (en) Oral composition comprising chlorhexinine and maltitol or erythritol or a mixture thereof
IL154240A0 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
IL159219A0 (en) Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them
AU2002341555A1 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
MXPA03009689A (en) A pharmaceutical tablet having a high api content.